• Revenues for the quarter were SEK 8.5 million (3.5).
• Operating result was SEK -5.7 million during the quarter (-9.0).
• The Group's result after financial items was SEK -6.1 million (-9.0) during the quarter.
• Earnings per share, attributable to the shareholders of the Parent Company, totaled SEK -0.12 (-0.20) during the quarter.
• Equity was SEK 52.3 million (62.2) or SEK 1.01 per share (1.37) as at the balance sheet date.
• Debt/equity ratio was 58% as at the balance sheet date (85%).
• Cash flows from operating activities were SEK -3.5 million (-14.2) during the quarter.
• As at the balance sheet date, the Group's cash and cash equivalents totaled SEK 23.6 million (32.1).

Significant events in the period

• July 15, 2020 | Cell Impact secures an order for production tools for serial production.
• July 31, 2020 | Cell Impact secures an additional order for production tools for serial production.
• August 4, 2020 | Positive final result of high-volume testing.
• September 2, 2020 | Beijing Nowogen Technology places an order for the production of flow plates.